Article
Role of CYP1A2 polymorphisms in breast cancer risk in women.
Molecular medicine reports - 1 Jan 2013
Ayari Imene, Fedeli Ugo, Saguem Saad, Hidar Samir, Khlifi Saida, Pavanello Sofia
Abstract excerpt
Cytochrome P4501A2 (CYP1A2) is a key enzyme in the etiology of breast cancer (BC). It is involved in breast carcinogen activation [aromatic (AAs) and heterocyclic amines (HAs), polycyclic aromatic hydrocarbons (PAHs)], in the production of beneficial oestrogen [2-hydroxyestrone (2-OHE1)] and in converting arachidonic acid (AAc) to epoxyeicosatrienoic acids (EETs), which have anti-inflammatory properties. Within a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
